Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Sarcopenia 1Muscle Weakness 1Motor Activity 1

Interventions

Fulvestrant 125Trastuzumab 115Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Anastrozole 72Capecitabine 71Cyclophosphamide 69Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 61trastuzumab deruxtecan 58Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 48Magnetic Resonance Spectroscopy 48Docetaxel 48Blood Specimen Collection 40olaparib 39Standard of Care 37Biopsy 34sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Exercise 29Doxorubicin 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Creatine × 1 year × Clear all
NCT07372144 2026-01-28

IARA

D'Or Institute for Research and Education

Phase 3 Not yet recruiting
227 enrolled
Breast

Breast Neoplasms

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡